Clinical Trial: Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07402915) titled 'Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer' on Jan. 23.

Brief Summary: The purpose of this study is to assess the effect of itraconazole on the pharmacokinetics (PK) of AZ14170132.

Study Start Date: Jan. 26

Study Type: INTERVENTIONAL

Condition: Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal

Intervention: DRUG: AZD5335

AZD5335 will be administered as IV infusion.

DRUG: Itraconazole

Itraconazole capsule will be administered orally.

Recruitment Status: RECRUITING

Sponsor: AstraZeneca

Disclaimer: Curated by HT Syndication....